11.3 Generic Substitution & Product Selection

11.3 Generic Substitution & Product Selection

Quick Answer: Under Minn. Stat. §151.21, a pharmacist may not substitute a different article than ordered without a lawful pathway. If the prescriber has handwritten “dispense as written” or “D.A.W.” (paper), expressly indicated DAW on a compliant electronic prescription, or expressly stated DAW on an oral order, dispense as prescribed. Otherwise, when a less expensive generically equivalent drug—or FDA-interchangeable biological product—is in stock, the pharmacist shall, after disclosing the substitution, dispense it unless the purchaser objects, and only when professional judgment supports therapeutic equivalence (drugs) or FDA interchangeability (biologics).

Product selection is NABP Area 4 (operations) competency 4.4, but it is graded on every outpatient fill. Minnesota’s statute is a mandatory substitution model with patient-objection and DAW brakes—not a pure “pharmacist may if desired” optional system.

Baseline Prohibition — §151.21, Subd. 1

Except as the section provides, it is unlawful for a pharmacist or pharmacist intern to substitute an article different from the one ordered or to deviate from the prescription drug order without the prescriber’s approval. Everything else in §151.21 is an authorized exception structure, not free-form rewriting of therapy.

Dispense-as-Written Orders — Subd. 2

Dispense the drug as prescribed when:

1. Paper/hard copy: the prescriber has personally written in handwriting “dispense as written” or “D.A.W.”
2. Electronic: the prescriber has expressly indicated, in a manner consistent with federal e-prescribing standards under 42 CFR 423, that the prescription is to be dispensed as transmitted, with the prescriber’s electronic signature
3. Oral: the prescriber has expressly indicated that the order is to be dispensed as communicated

Subd. 3a forbids maintaining DAW as a default on all electronic prescriptions—prescribers must add DAW individually when appropriate. A pre-checked DAW for every drug is not a valid Minnesota product-selection lock.

When Substitution Is Required — Subd. 3

If there is no valid DAW as above, and the pharmacy has a less expensive generically equivalent drug (or less expensive interchangeable biological product) in stock, then the pharmacist shall, after disclosing the substitution to the purchaser, dispense that product unless the purchaser objects. The pharmacist may also substitute pursuant to the prescriber’s oral instructions.

Critical judgment gates:

• A pharmacist may not substitute a generically equivalent drug unless, in the pharmacist’s professional judgment, the substitute is therapeutically equivalent and interchangeable to the prescribed drug.
• A pharmacist may not substitute a biological product unless the FDA has determined the substitute to be interchangeable with the prescribed biologic.
• The pharmacist must notify the purchaser if dispensing a drug or biologic other than the specific product prescribed.

Orange Book principles (professional judgment tool)

The statute does not force you to recite Orange Book codes on every fill, but FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) is the standard national reference for whether multi-source drugs are therapeutically equivalent. Products rated AB (or other “A” codes indicating therapeutic equivalence to a reference listed drug) are the usual safe basis for concluding two products are interchangeable under professional judgment. If the Orange Book does not support equivalence—or you have no other legitimate, documented basis—do not force a substitution; contact the prescriber and document. Minnesota Board FAQ guidance has long emphasized that professional judgment needs a documented basis, not a hunch.

Pricing, Sign, Disclosure, and Plan Limits

Extended Supply — Subd. 9

After an initial 30-day supply (unless a prior fill was already 90 days), a pharmacist may dispense up to a 90-day supply on refill if total units do not exceed remaining authorized refills and judgment supports it. The pharmacist may not exceed authorized units if the prescriber limited quantity for medical necessity, or if the drug is a controlled substance under §152.01.

Biological Products — Subd. 10

Within five business days after dispensing a biological product, communicate the name and manufacturer of the product dispensed to the prescriber, preferably via electronic records systems accessible to the prescriber. Electronic entry is presumed notice. If electronic notice is impossible, use mail, fax, phone, or other secure electronic means. Notice is not required if there is no FDA-approved interchangeable biologic for the product prescribed, or if a refill dispenses the same biologic as the prior fill.

Worked Decision Tree

1. Is there valid DAW / dispense as written? → Dispense as prescribed.
2. If not, is a less expensive generically equivalent / FDA-interchangeable product in stock?
3. Does professional judgment (Orange Book or documented basis) support interchange?
4. Disclose to purchaser; honor objection.
5. Price at not higher than prescribed; choose least expensive among safe options.
6. Label with the product actually dispensed (name/manufacturer as required).
7. For biologics, complete subd. 10 communication when required.

Common Exam Traps

• Accepting a typed or stamped “DAW” on paper as handwritten DAW
• Ignoring patient objection after “mandatory” substitution language
• Substituting a non-interchangeable biosimilar that is not FDA-interchangeable
• Forcing 90-day supplies of controlled substances under subd. 9
• Forgetting the posted sign or least expensive pricing rule

Study Checklist

1. Distinguish subd. 2 DAW modalities (paper handwriting / e-Rx / oral).
2. Apply shall substitute vs purchaser objects vs professional judgment.
3. Connect Orange Book therapeutic equivalence to judgment.
4. Recite sign, pricing, formulary, biologic 5-day notice.
5. Know 90-day extended supply limits and CS exclusion.

Product selection is both a cost-savings mandate and a clinical equivalence duty—fail either side and the fill is wrong.